Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Thoracic Malignancies
What would be your post-operative therapy approach for a high grade neuroendocrine carcinoma of the thymus?
What if there was mediastinal nodal involvement?
Answer from: Radiation Oncologist at Academic Institution
Postoperative RT.
Sign In
or
Register
to read more
13071
Related Questions
Would you offer SBRT for primary pulmonary adenoid cystic carcinoma in a patient who was medically not a surgical candidate?
Would you give durvalumab consolidation to a patient with stage III NSCLC with an STK11 mutation?
What are your top takeaways in thoracic cancers from ESMO 2025?
Is there a role for the addition of radiation to preoperative chemoimmunotherapy in NSCLC with limited N2 disease planned for surgery?
What radiation treatment volume would you include in chemoradiation given for perihilar lymph node recurrence after surgical resection and mediastinal lymph node dissection for NSCLC?
Do you use an LAD constraint in the setting of BID thoracic radiation for SCLC?
How do you assess whether a patient will be a good DIBH candidate for lung or abdomen treatments?
What is the recommendation for persistent PET uptake and elevated catecholamines at 4 months following subtotal resection and adjuvant radiation for a thoracic secretory paraganglioma?
Would you treat a patient with an N2 ipsilateral recurrence following re-resection of bronchial stump recurrence?
In resected N2 NSCLC, what nodal pathologic characteristics prompt you to recommend PORT?